Speaker :

Dr. Shruti Kate, Medical Oncologist, Nasik

TBCRC 048: A phase II study of olaparib monotherapy in metastatic breast cancer patients with germline or somatic mutations in DNA damage response (DDR) pathway genes (Olaparib Expanded).

Author: Nadine M. Tu  

Citation: Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020) 1002-100

Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial

Author: Yu, Ke-Da

Citation: JAMA oncology vol. 6,9 (2020): 1390-1396